Lv3
340 积分 2024-09-14 加入
Prediction of Drug–Drug Interactions with Ensartinib as a Time-Dependent CYP3A Inhibitor Using Physiologically Based Pharmacokinetic Model
13天前
已完结
Desmopressin tablet treatment: factors influencing gastrointestinal absorption
22天前
已关闭
A PHARMACOKINETIC AND PHARMACODYNAMIC COMPARISON OF DESMOPRESSIN ADMINISTERED AS WHOLE, CHEWED AND CRUSHED tablets, AND AS AN ORAL SOLUTION
22天前
已完结
Tu1744 – Targeted Release Oral Cyclosporine (ST-0529) As a Potential New Therapy for Ulcerative Colitis: Phase I Study Results
1个月前
已完结
P120 BBT-401 IS A SELECTIVE PELLINO-1 PROTEIN-PROTEIN INTERACTION INHIBITOR IN CLINICAL DEVELOPMENT TARGETING A FIRST-IN-CLASS DRUG FOR UC TREATMENT
1个月前
已完结
POS0899 FIRST-IN-HUMAN SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS DATA WITH MK-6194, A MODIFIED FORM OF INTERLEUKIN-2, DESIGNED TO SELECTIVELY ACTIVATE REGULATORY T-CELLS – SINGLE ASCENDING DOSE AND MULTIPLE ASCENDING DOSE TRIALS
1个月前
已完结
Use of Synbiotics for Ulcerative Colitis Treatment
6个月前
已完结
ulcerative cokitis:pathogenesis
6个月前
已完结
SPH7854, a gut-limited RORγt antagonist, ameliorates TNBS-induced experimental colitis in rat
7个月前
已完结
皖公网安备34019202002308
